Market Overview

US Stock Futures Edge Lower Ahead Of Housing Market Index

US Stock Futures Edge Lower Ahead Of Housing Market Index
Related TOL
NAILing Down A Leveraged Homebuilders ETF
5 Biggest Price Target Changes For Thursday
Related AZN
Here's Why Nektar Stock Skyrocketed Almost 500% In A Year
Pieris' Artificial Protein Platform Is Undervalued By The Street, Analyst Says
Your Daily Pharma Scoop: Ablynx Takeover Battle, Acorda Takeover Speculation, Oramed Update (Seeking Alpha)

Pre-open movers

US stock futures traded slightly lower in early pre-market trade. The housing market index for May will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average dropped 7.50 points to 18,221.50, while the Standard & Poor's 500 index futures fell 2.35 points to 2,116.65. Futures for the Nasdaq 100 index slipped 7.85 points to 4,480.90.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index falling 0.71 percent, STOXX Europe 600 Index declining 0.44 percent and German DAX 30 index dropping 0.09 percent. French CAC 40 Index slipped 0.76 percent and London's FTSE 100 Index fell 0.19 percent.

In Asian markets, Japan's Nikkei Stock Average rose 0.80 percent, China's Shanghai Composite Index fell 1.59 percent, Hong Kong's Hang Seng Index declined 0.83 percent and India's BSE Sensex jumped 1.33 percent.

Broker Recommendation
Analysts at Sterne Agee CRT upgraded Toll Brothers Inc (NYSE: TOL) from Underperform to Neutral.

Toll Brothers shares rose 1.82 percent to close at $37.39 on Friday.

Breaking news

  • AstraZeneca (NYSE: AZN) today announced that it plans to invest approximately $285 million in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. To read the full news, click here.
  • Archer Daniels Midland Company (NYSE: ADM) announced today that it has reached an agreement to purchase Meiweiyuan Biotechnology Co., a privately held sweetener manufacturer near the city of Wuhan, in the central Chinese province of Hubei. To read the full news, click here.
  • KBR (NYSE: KBR) announced today that it won its appeal in the U.S. Court of Appeals for the Ninth Circuit. To read the full news, click here.
  • Pluristem Therapeutics Inc. (NASDAQ: PSTI) today announced a significant advancement to its clinical development plan: the PLX cell program in critical limb ischemia has been selected for the European Medicines Agency's Adaptive Pathways pilot project. To read the full news, click here.

Posted-In: Sterne Agee CRT US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (ADM + AZN)

View Comments and Join the Discussion!